A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials-Reference-Cited by-同舟云学术

A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials

Published:2020-05-29 Issue:5 Volume:15 Page:e0233705
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Geng Xinghua,Shi Ermin,Wang Shiwei,Song Yuzhi^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;GA Block;J Am Soc Nephrol,2004

2. Clinical epidemiology of cardiovascular disease in chronic renal disease;RN Foley;Am J Kidney Dis,1998

3. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients;K Kalantar-Zadeh;Kidney Int,2006

4. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism;M Rodriguez;Am J Physiol Renal Physiol,2005

5. Chronic kidney disease-mineral-bone disorder: a new paradigm.;S.M Moe;Adv Chronic Kidney Dis,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy;Clinical Medicine;2024-09

2. The impact of accessibility to non-calcium-based phosphate binders and calcimimetics on mineral outcomes in patients receiving maintenance hemodialysis: A 10-year retrospective analysis of real-world data;PLOS ONE;2024-05-31

3. Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study;Journal of Medical Internet Research;2024-05-03

4. Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities;Endokrynologia Polska;2023-10-30

5. Hydroxysafflor Yellow A-Induced Osteoblast Differentiation and Proliferation of BM-MSCs by Up-Regulating Nuclear Vitamin D Receptor;Current Molecular Medicine;2023-06